A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for ER+, HER 2- Breast Cancer
10 locations incl. East Brunswick
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18 - 99
Code: NCT07540572·Phase 1, Phase 2·Recruiting